Bayesian Capital Management’s Medallia, Inc. MDLA Stock Holding History

Bayesian Capital Management’s Portfolio MDLA Stock Details MDLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-8,000	Closed	-$202K	–	759
2020 Q2	$202K	Sell	8,000 -22,677	-74%	-$541K	0.04%	437
2020 Q1	$615K	Buy	+30,677	New	+$825K	0.13%	236

Other funds holding MDLA

SUT

SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SCGE Management Menlo Park, California $3.3B AUM 18.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Bayesian Capital Management's MDLA Position: Q3 2020 in Review

Bayesian Capital Management sold out of Medallia, Inc. (MDLA) in Q3 2020, closing a stake of 8,000 shares — an estimated $202K sold.

Bayesian Capital Management first reported a position in MDLA in Q1 2020 and held it in 2 quarters. The position peaked at $615K in Q1 2020. 172 funds tracked by Wall St. Rank hold MDLA as of Q3 2020.

Bayesian Capital Management reported no remaining Medallia, Inc. position as of Q3 2020 after selling out during the quarter.
Bayesian Capital Management sold 8,000 Medallia, Inc. shares in Q3 2020, an estimated $202K.
Bayesian Capital Management first reported a position in Medallia, Inc. in Q1 2020 and held it in 2 quarters.
Bayesian Capital Management's Medallia, Inc. position peaked at $615K in Q1 2020.
172 funds tracked by Wall St. Rank held Medallia, Inc. as of Q3 2020.

Based on Bayesian Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.